We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-13.46%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.59B
AUM Growth
-$417M
Cap. Flow
-$178M
Cap. Flow %
-6.89%
Top 10 Hldgs %
30.75%
Holding
151
New
30
Increased
31
Reduced
32
Closed
17

Top Buys

Rank Stock Value
1
GBT
Global Blood Therapeutics, Inc.
GBT
+$42M
2
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$38M
3
AAC
AAC Holdings
AAC
+$37.8M
4
GSK icon
GSK
GSK
+$37.7M
5
RGNX icon
Regenxbio
RGNX
+$34.1M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$132M
2
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$38M
3
INGN icon
Inogen
INGN
+$26.8M
4
AERI
Aerie Pharmaceuticals
AERI
+$25.4M
5
BSX icon
Boston Scientific
BSX
+$24.9M

Sector Composition

Rank Sector Weight
1 Healthcare 68.89%
2 Financials 4.77%
3 Technology 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSX icon
126
Boston Scientific
BSX
$65.4B
– –
-1,405,348
Closed -$24.9M
EXEL icon
127
PUT
Exelixis
EXEL
$14.1B
– –
-4,000,000
Closed -$15M
HUM icon
128
Humana
HUM
$48B
– –
-75,500
Closed -$14.4M
IART icon
129
Integra LifeSciences
IART
$1.5B
– –
-145,487
Closed -$4.01M
INGN icon
130
Inogen
INGN
$178M
– –
-601,772
Closed -$26.8M
INSM icon
131
Insmed
INSM
$23.5B
– –
-891,546
Closed -$21.8M
IRWD icon
132
Ironwood Pharmaceuticals
IRWD
$635M
– –
-76,058
Closed -$768K
PRGO icon
133
Perrigo
PRGO
$1.48B
– –
-3,500
Closed -$647K
IMMU
134
DELISTED
Immunomedics Inc
IMMU
– –
-2,505,872
Closed -$10.2M
DERM
135
DELISTED
Dermira, Inc.
DERM
– –
-496,387
Closed -$8.71M
ONCE
136
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-631,192
Closed -$38M
JUNO
137
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-183,149
Closed -$9.77M
STJ
138
DELISTED
St Jude Medical
STJ
– –
-107,719
Closed -$7.87M
ZSPH
139
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
– –
-132,000
Closed -$6.92M
RCPT
140
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
– –
-2,000
Closed -$380K
2 3 4 5
6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $8.5B AUM 25.14% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return

Deerfield Management's Q3 2015 Portfolio in Review

As of Q3 2015, Deerfield Management held 151 positions worth $2.59B, down 14% from $3B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Deerfield Management withdrew a net $178M in Q3 2015, closing 17 positions and reducing 32 holdings. Its most notable exit was Spark Therapeutics, Inc. Common Stock, an estimated $38M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 71% a quarter earlier, followed by Financials and Technology.

Against the trend, Deerfield Management opened a new position in Global Blood Therapeutics, Inc. worth $37.5M.

  • Deerfield Management's largest Q3 2015 buy was Global Blood Therapeutics, Inc.: 890,620 shares worth $37.5M.
  • Deerfield Management added most to AAC Holdings in Q3 2015, an estimated $37.8M increase.
  • Deerfield Management's biggest Q3 2015 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $132M.
  • Deerfield Management fully exited Spark Therapeutics, Inc. Common Stock in Q3 2015, selling an estimated $38M.
  • Deerfield Management's ten largest holdings make up 31% of its $2.59B portfolio in Q3 2015.
  • Deerfield Management opened 30 new positions and closed 17 in Q3 2015.
  • Deerfield Management's portfolio value fell 14% quarter-over-quarter to $2.59B.

Based on Deerfield Management's 13F filing for Q3 2015, filed 16 Nov 2015.